RGA Investment Advisors Q1 2024 Investment Commentary [Seeking Alpha]
MaxCyte, Inc. (MXCT)
Company Research
Source: Seeking Alpha
We sold down a portion of our stake in one of the world's largest companies to finance investments in smaller-cap life science firms and an international life science company. As we continue to strengthen our team and enhance our capabilities, we are thrilled to announce that Ryan King has joined us as a Senior Investment Advisor and Analyst. In the first quarter, the macroeconomic environment was characterized by persistently strong economic growth alongside frustratingly resilient inflation. Although small caps had regained some ground relative to large caps at the end of 2023, the first quarter once again saw large caps outperform their smaller counterparts. This may have resulted from a modest resurgence in inflation or possibly the continued influence of market momentum. Regardless of the underlying causes, these conditions have remained a focal point for us. Accordingly, we made several strategic adjustments during the first quarter that warrant-specific mention: We modes
Show less
Read more
Impact Snapshot
Event Time:
MXCT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MXCT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MXCT alerts
High impacting MaxCyte, Inc. news events
Weekly update
A roundup of the hottest topics
MXCT
News
- Porton Advanced introduces the MaxCyte ExPERT GTx Flow Electroporation instrument, continuing to provide customers with end-to-end cell and gene therapy CRO & CDMO services [Yahoo! Finance]Yahoo! Finance
- President of MaxCyte Maher Masoud Buys More Stock [Yahoo! Finance]Yahoo! Finance
- Does MaxCyte (MXCT) Have the Potential to Rally 85% as Wall Street Analysts Expect? [Yahoo! Finance]Yahoo! Finance
- Recent Price Trend in MaxCyte (MXCT) is Your Friend, Here's Why [Yahoo! Finance]Yahoo! Finance
- MaxCyte to Participate in William Blair 44th Annual Growth Stock ConferenceGlobeNewswire
MXCT
Earnings
- 5/7/24 - Beat
MXCT
Sec Filings
- 6/24/24 - Form 4
- 6/20/24 - Form 144
- 6/13/24 - Form 4
- MXCT's page on the SEC website